Abstract
FLT3-Mutated Acute Myeloid Leukemia Using a Novel Regimen of Gemtuzumab Ozogamicin and Midostaurin in Combination with Standard Cytarabine and Daunorubicin Induction Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have